Galderma Group AG
Efficacy and Safety Study of CD2027 Ointment 3 Microgram Per Gram (mcg/g) Twice Daily Treatment for Adults With at Least Moderate Atopic Dermatitis
- Conditions
- Interventions
- First Posted Date
- 2009-06-12
- Last Posted Date
- 2022-07-19
- Lead Sponsor
- Galderma R&D
- Target Recruit Count
- 102
- Registration Number
- NCT00919763
- Locations
- 🇺🇸
Helendale Dermatology & Medical Spa, LLC, Rochester, New York, United States
🇺🇸Minnesota Clinical Study Center, Fridley, Minnesota, United States
🇺🇸Therapeutics Clinical Research, Inc., San Diego, California, United States
Evaluate Effectiveness of Epiduo® Gel in Reducing Antibiotic Sensitive & Resistant Strains of Propionibacterium (P)Acnes
- Conditions
- Interventions
- First Posted Date
- 2009-05-22
- Last Posted Date
- 2022-08-01
- Lead Sponsor
- Galderma R&D
- Target Recruit Count
- 30
- Registration Number
- NCT00907101
- Locations
- 🇺🇸
Skin Study Center, Broomall, Pennsylvania, United States
ORCA - Oracea® for Rosacea: A Community-based Assessment
- Conditions
- Interventions
- First Posted Date
- 2009-05-04
- Last Posted Date
- 2022-08-25
- Lead Sponsor
- Galderma R&D
- Target Recruit Count
- 1421
- Registration Number
- NCT00892281
- Locations
- 🇺🇸
REGISTRAT® - MAP1, Inc. (CRO), Lexington, Kentucky, United States
Comparison of Four Different Regimens of Adapalene 0.1% / Benzoyl Peroxide 2.5% Gel in Acne Vulgaris
- First Posted Date
- 2009-04-17
- Last Posted Date
- 2021-02-18
- Lead Sponsor
- Galderma R&D
- Target Recruit Count
- 123
- Registration Number
- NCT00883233
- Locations
- 🇨🇦
Galderma Investigational Site, Montreal, Quebec, Canada
Clobetasol Propionate Spray Versus Vehicle Spray for the Management of Moderate to Severe Plaque Psoriasis of the Scalp
- Conditions
- Interventions
- First Posted Date
- 2009-04-15
- Last Posted Date
- 2022-08-25
- Lead Sponsor
- Galderma R&D
- Target Recruit Count
- 81
- Registration Number
- NCT00881868
- Locations
- 🇺🇸
Hudson Dermatology, Evansville, Indiana, United States
🇺🇸Dermatology Associates, PLLC, Seattle, Washington, United States
🇺🇸Research Division of The Skin Specialty Group, New York, New York, United States
Clobetasol Propionate 0.05% Shampoo in Association With Antifungal Shampoo in Scalp Seborrheic Dermatitis
- First Posted Date
- 2009-03-17
- Last Posted Date
- 2021-02-18
- Lead Sponsor
- Galderma R&D
- Target Recruit Count
- 326
- Registration Number
- NCT00862654
- Locations
- 🇲🇽
Galderma Investigational Center, Zapopan, Jalisco, Mexico
Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of CD 2027 Spray in Adults With Plaque-type Psoriasis
- First Posted Date
- 2008-10-01
- Last Posted Date
- 2021-02-18
- Lead Sponsor
- Galderma R&D
- Target Recruit Count
- 26
- Registration Number
- NCT00763503
- Locations
- 🇺🇸
J & S Studies, Bryan, Texas, United States
🇺🇸Burke Pharmaceutical Research, Hot Springs, Arizona, United States
🇺🇸DermResearch, Austin, Texas, United States
Efficacy and Safety Study of CD 2027 Spray in Subjects With Plaque-type Psoriasis
- First Posted Date
- 2008-10-01
- Last Posted Date
- 2022-08-23
- Lead Sponsor
- Galderma R&D
- Target Recruit Count
- 88
- Registration Number
- NCT00763555
- Locations
- 🇨🇦
K. Papp Clinical Research, Inc., Waterloo, Ontario, Canada
🇨🇦North Bay Dermatology Centre, North Bay, Ontario, Canada
🇺🇸Minnesota Clinical Study Center, Fridley, Minnesota, United States
Efficacy/Safety/Subject Satisfaction/Duration of Response of Clobetasol Propionate Spray vs Ointment in Plaque Psoriasis
- Conditions
- Interventions
- First Posted Date
- 2008-08-13
- Last Posted Date
- 2022-08-23
- Lead Sponsor
- Galderma R&D
- Target Recruit Count
- 250
- Registration Number
- NCT00733954
- Locations
- 🇺🇸
Solano Clinical Research, Vallejo, California, United States
🇺🇸Henry Ford Medical Center, Detroit, Michigan, United States
🇺🇸Baylor Research Institute - Dermatology Research, Dallas, Texas, United States
Evaluate Efficacy, Safety & Subject Satisfaction of Pain Management With Pliaglis® Cream for Dermal Filler Injections
- Conditions
- Interventions
- First Posted Date
- 2008-07-16
- Last Posted Date
- 2022-08-23
- Lead Sponsor
- Galderma R&D
- Target Recruit Count
- 51
- Registration Number
- NCT00716443
- Locations
- 🇺🇸
Premier Clinical Research, Spokane, Washington, United States
🇺🇸Sadick Dermatology, New York, New York, United States
🇺🇸Skin and Cancer Associates, Center for Cosmetic Enhancement, Aventura, Florida, United States